[The current concepts of microscopic polyarteritis]

Terapevticheskii Arkhiv
|January 1, 1995
PubMed

Insights

Microscopic polyangiitis (MPA) is a distinct disease, confirmed by clinical, morphological, and immunological findings. Differentiating MPA from other systemic vasculitis is crucial for personalized treatment strategies.

Area of Science:

  • Immunology
  • Pathology
  • Rheumatology

Context:

  • Systemic vasculitis encompasses a group of rare diseases characterized by inflammation of blood vessels.
  • Microscopic polyangiitis (MPA) is a specific subtype requiring accurate diagnosis.
  • Distinguishing MPA from other vasculitides is essential for effective management.

Purpose:

  • To confirm the independent nosological status of MPA.
  • To highlight the importance of accurate diagnosis in systemic vasculitis.

Summary:

  • Clinical presentation, morphological alterations, and immunological abnormalities provide definitive evidence for MPA's reality and distinct classification.
  • These findings underscore the necessity of precise nosological differentiation among systemic vasculitis for tailoring patient treatment.

Impact:

  • Establishes MPA as a distinct entity, aiding in precise diagnosis.
  • Informs individualized treatment decisions for patients with systemic vasculitis, potentially improving outcomes.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...